Helicobacter pylori infection and the pathogenesis of duodenal ulceration

Annals of the New York Academy of Sciences

Volumn 859, Issue , 1998, Pages 96-111

  Walker, M M ^a   Crabtree, J E ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CHEMOKINE; TOXIN;

ACID SECRETION; BACTERIAL VIRULENCE; CELLULAR IMMUNITY; CONFERENCE PAPER; DUODENITIS; DUODENUM MUCOSA; DUODENUM ULCER; EPITHELIUM; ERADICATION THERAPY; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HELPER CELL; HUMAN; IMMUNE RESPONSE; INTESTINE METAPLASIA; PATHOGENESIS; STOMACH EPITHELIUM; T LYMPHOCYTE; ULCER HEALING;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI; NEGIBACTERIA;

EID: 0032420217     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb11114.x     Document Type: Conference Paper

References (105)

1. 1. MARSHALL, B. J. & J. R. WARREN. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet i: 1311-1315.
2. 2. AXON A. T. R. & D. FORMAN. 1997. Helicobacter gastroduodenitis: A serious infectious disease. Br. Med. J. 314: 1430-1431.
3. 3. RAUWS, E. A. & G. N. J. TYTGAT. 1990. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 325: 1233-1236.
4. 4. MCGOWAN, C. C., T. L. COVER & M. J. BLASER. 1996. Helicobacter pylori and gastric acid: Biological and therapeutic implications. Gastroenterology 110: 926-938.
5. 5. Moss, S. F. et al. 1992. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 340: 930-932.
6. 6. EL-OMAR, E. M. et al. 1995. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 109: 681-691.
7. 7. GRAHAM, D. Y., G. M. LEW & J. LECHARGO. 1993. Antral G-cell and D-cell numbers in Helicobacter pylori infection: Effect of H. pylori eradication. Gastroenterology 104: 1655-1660.
8. 8. COURILLON MALLET, A. et al. 1995. Helicobacter pylori infection: Physiologic implication of N alpha methyl histamine. Gastroenterology 108: 959-966.
9. 9. WALKER, M. M. et al. 1996. D cells in the antrum are decreased in Helicobacter pylori positive patients with duodenal ulcer due to active inflammation in the foveolar pits. Gastroenterology 110: A290.
10. 10. CRABTREE, J. E. et al. 1991. Mucosal tumour necrosis factor-α and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 32: 1473-1477.
11. 11. CRABTREE, J. E. et al. 1994. Interleukin 8 expression in Helicobacter pylori infected, normal and neoplastic gastroduodenal mucosa. J. Clin. Pathol. 47: 61-66.
12. 12. YAMAOKA, Y. et al. 1997. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 41: 442-451.
13. 13. BEALES, I. et al. 1997. Effect of tumour necrosis factor-α and interleukin 8 on somatostatin release from canine fundic D cells. Gastroenterology 112: 136-143.
14. 14. WEIGERT, N. et al. 1996. Gastrin secretion from primary cultures of rabbit antral G cells: Stimulation by inflammatory cytokines. Gastroenterology 110: 147-154.
15. 15. LEHMANN, F. S. et al. 1996. Mononuclear cells and cytokines stimulate gastrin release from canine antral cells in primary culture. Am. J. Physiol. 270: G783-G788.
16. 16. BEALES, I. et al. 1997. Effect of Helicobacter pylori products and recombinant cytokines on gastrin release from cultured canine G cells. Gastroenterology 113: 465-471.
17. 17. PHULL, P. S. et al. 1996. Histology of chronic gastritis with and without duodenitis in patients with Helicobacter pylori infection. J. Clin. Pathol. 49: 377-380.
18. 18. HAMLET, A. & L. OLBE. 1996. The influence of Helicobacter pylori infection on postprandial duodenal acid load and duodenal bulb pH in humans. Gastroenterology 111: 391-400.
19. 19. HOGAN, D. L. et al. 1996. Duodenal bicarbonate secretion: Eradication of Helicobacter pylori and duodenal structure and function in humans. Gastroenterology 110: 705-716.
20. 2 are increased in duodenal ulcer patients but not in Helicobacter pylori positive healthy subjects. Scand. J. Gastroenterol. 31: 38-43.
21. 21. HOGAN, D. L., M. A. AINSWORTH & J. I. ISENBERG. 1994. Review article: Gastroduodenal bicarbonate secretion. Aliment. Pharmacol. Ther. 8: 475-488.
22. 22. FANDRICKS, L. et al. 1997. Water extract of Helicobacter pylori inhibits duodenal mucosal alkaline secretion in anaesthetized rats. Gastroenterology 113: In press.
23. 23. DAY, D. W. & M. F. DIXON. 1995. Biopsy pathology of the esophagus, stomach and duodenum: 253-258. Chapman and Hall. London.
24. 24. LAWSON, H. H. 1988. Definition of gastroduodenal junction in healthy subjects. J. Clin. Path. 41: 393-396.
25. 25. WALKER, M. M. & M. F. DIXON. 1996. Gastric metaplasia: Its role in duodenal ulceration. Aliment. Pharmacol. Ther. 10(Suppl. 1): 119-128.
26. 26. ANON. 1985. Duodenitis - any progress? Lancet ii: 1222-1223.
27. 27. JOFFE, S. N., F. D. LEE & L. H. BLUMGART. 1978. Duodenitis. Clin. Gastroenterol. 7: 635-650.
28. 28. DAY, D. W. & M. F. DIXON. 1995. Biopsy pathology of the esophagus, stomach and duodenum: 259-278. Chapman and Hall. London.
29. 29. HANBY, A. M. et al. 1993. The expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in "gastric metaplasia" of the proximal duodenum: Implications for the nature of "gastric metaplasia." J. Pathol. 169: 355-360.
30. 30. KHULUSI, S. et al. 1995. Expression of trefoil peptides pS2 and human spasmolytic polypeptide in gastric metaplasia at the margin of duodenal ulcers. Gut 37: 205-209.
31. 31. HARRIS, A. W. et al. 1996. The relationship between gastric acid output and gastric metaplasia of the duodenal bulb. Gut. 39: 513-520.
32. 32. KHULUSI, S. et al. 1996. Pathogenesis of gastric metaplasia of the human duodenum: Role of Helicobacter pylori, gastric acid, and ulceration. Gastroenterology 110: 452-458.
33. 33. WYATT, J. I. et al. 1987. Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J. Clin. Path. 40: 841-848.
34. 34. CARRICK, J. et al. 1989. Campylobacter pylori, duodenal ulcer and gastric metaplasia: Possible role of functional heterotopic tissue in ulcerogenesis. Gut 30: 790-797.
35. 35. WALKER, M. M. et al. 1993. The influence of Helicobacter pylori eradication on the structure of duodenal ulcer scars. Eur. J. Gastroenterol Hepatol. 5 (Suppl 3): S97-98.
36. 36. CRABTREE J. E. et al. 1991. Mucosal humoral response to Helicobacter pylori in patients with duodenitis. Dig. Dis. Sci. 36: 1266-1273.
37. 37. NOACH, L. A. et al. 1993. Gastric metaplasia and Helicobacter pylori infection. Gut 34: 1510-1514.
38. 38. NOACH, L. A. et al. 1995. Acid and gastric metaplasia in the duodenum Gut 36: 154.
39. 39. GIACOSA, A., O. CRIVELLI & R. CHELI. 1989. The distribution of duodenal G cells in duodenal ulcer patients. Scand. J. Gastroenterol. 24( Suppl 167): 58-59.
40. 40. HARRIS, A. W. et al. 1995. H. pylori positive patients with duodenal ulcer have increased D cell counts in the duodenal bulb. Gut 37(Suppl 2): A44.
41. 41. JENSEN, S. L. et al. 1987. Altered concentrations of gastrin-releasing polypeptide and somatostatin in fundic and duodenal bulb mucosa of patients with duodenal ulcer disease. Am. J Gastroenterol. 82: 410-414.
42. 42. SHULKES, A. 1994. Somatostatin: Physiology and clinical applications. Baillieres Clin. Endocrinol. Metab. 8: 215-236.
43. 43. AKOPYANTS, N. S. et al. 1992. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acid Res. 20: 5137-5142.
44. 44. COVER, T. L. 1996. The vacuolating cytotoxin of Helicobacter pylori. Mol. Microbiol. 20: 241-246.
45. 45. CRABTREE, J. E. et al. 1991. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration and gastric pathology. Lancet 338: 332-335.
46. 46. COVER, T. L., C. P. DOOLEY & M. J. BLASER. 1990. Characterisation of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolising cytotoxin activity. Infect. Immun. 58: 603-610.
47. 47. COVACCI, A. et al. 1993. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. USA 90: 5791-5795.
48. 48. TUMMURU, M. K. R., T. L. COVER & M. J. BLASER. 1993. Cloning and expression of a high-molecular mass major antigen of Helicobacter pylori: Evidence for linkage to cytotoxin production. Infect. Immun. 61: 1799-1809.
49. 49. CENSINI, S. et al. 1996. cag, a pathogenicity island of Helicobacter pylori, encodes Type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA 93: 14648-14653.
50. 50. FIGURA, N. et al. 1989. Cytotoxin production by Campylobacter pylori strains isolated from patients with chronic gastritis only. J. Clin. Microbiol. 27: 225-226.
51. 51. GOOSSENS, H. et al. 1992. Role of the vacuolating toxin from Helicobacter pylori in the pathogenesis of duodenal and gastric ulcer. Med. Microbiol. Lett. 1: 153-159.
52. 52. TEE, W. et al. 1995. Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract disease. J. Clin. Microbiol. 33: 1203-1205.
53. 53. RAUTELIN, H. et al. 1994. Nonopsonic activation of neutrophils and cytotoxin production by Helicobacter pylori: Ulcerogenic markers. Scand. J. Gastroenterol. 29: 128-132.
54. 54. TELFORD, J. L. et al. 1994. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J. Exp. Med. 179: 1653-1658.
55. 55. COVER, T. L. et al. 1994. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J. Biol. Chem. 269: 10566-10573.
56. 56. SCHMITT, W. & R. HAAS. 1994. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: Structural similarities with the IgA protease of exported protein. Mol Microbiol. 12: 307-319.
57. 57. ATHERTON, J. C. et al. 1995. Mosaicism in vacuolating cytotoxin of Helicobacter pylori. J. Biol. Chem. 270: 17771-17777.
58. 58. ATHERTON, A. et al. 1997. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 112: 92-99.
59. 59. ITO, Y. et al. 1997. Analysis and typing of the vacA gene from cagA -positive strains of Helicobacter pylori isolated in Japan. J. Clin. Microbiol. 35: 1710-1714.
60. 60. BERNARD, M. et al. 1995. Low pH activates the vacuolating toxin of Helicobacter pylori, which becomes acid and pepsin resistant. J. Biol. Chem. 270: 23937-23940.
61. 61. EATON, K. A. et al. 1997. Role of vacuolating cytotoxin in gastritis due to Helicobacter pylori in gnotobiotic piglets. Infect. Immun. 65: 3462-3464.
62. 62. GRAHAM, D. Y. et al. 1988. Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria. Am. J. Gastroenterol. 83: 974-980.
63. 63. RICCI, V. et al. 1996. Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: Role of VacA and CagA. Infect. Immun. 64: 2829-2833.
64. 64. ASCENCIO, F. et al. 1995. Helicobacter pylori interacts with heparin and heparin-dependent growth factors. FEMS Immunol. Med. Microbiol. 12: 265-272.
65. 65. TUMMURU, M. K. R., T. L. COVER & M. J. BLASER. 1994. Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect. Immun. 62: 2609-2613.
66. 66. TUMMURU, M. K. R., S. A. SHARMA & M. J. BLASER. 1995. Helicobacter pylori picB, a homolog of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol. Microbiol. 18: 867-876.
67. 67. YAMAOKA, Y. et al. 1996. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 110: 1744-1752.
68. 68. WEEL, J. F. L. et al. 1996. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J. Infect. Dis. 173: 1171-1175.
69. + Helicobacter pylori strains. J. Clin. Microbiol. 33: 1496-1500.
70. + proportion of Helicobacter pylori infections. Int. J. Cancer. 72: 453-456.
71. 71. CRABTREE, J. E. et al. 1996. An epidemiological survey of CagA seropositivity in seventeen worldwide populations. Gut 39(Suppl. 2): A82.
72. 72. PAN, Z. J. et al. 1997. Equally high prevalences of infection with cagA -positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J. Clin. Microbiol. 35: 1344-1347.
73. 73. MARCHETTI, M. et al. 1995. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 267: 1655-1658.
74. + Helicobacter pylori strains. Lab. Invest. 73: 760-70.
75. 75. DAVIES, G. R. et al. 1992. Mucosal reactive oxygen metabolite production in duodenal ulcer disease. Gut 33: 1467-1472.
76. 76. WEISS, S. J. 1989. Tissue destruction by neutrophils. N. Eng. J. Med. 320: 365-376.
77. 77. NORAARD, A., L. P. ANDERSEN & H. NIELSEN. 1995. Neutrophil degranulation by Helicobacter pylori proteins. Gut 36: 354-357.
78. 78. YOSHIDA, N. et al. 1993. Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology 105: 1431-1440.
79. 79. NEILSEN, H. & L. P. ANDERSEN. 1992. Chemotactic activity of Helicobacter pylori sonicate for human polymorphonuclear leucocytes. and monocytes. Gut 33: 738-742.
80. 80. KUROSE, I. et al. 1994. Helicobacter pylori-induced microvascular protein leakage in rats: role of neutrophils, mast cells and platelets. Gastroenterology 107: 70-79.
81. 81. NEILSEN, H. et al. 1994. Neutrophil activation by Helicobacter pylori lipopolysaccharide. J. Infect. Dis. 170: 135-139.
82. 82. CRAIG, P. M. et al. 1992. Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. Gut 33: 1020-1023.
83. 83. NIELSEN, H. & L. P. ANDERSEN. 1992. Activation of human phagocytic oxidative metabolism by Helicobacter pylori. Gastroenterology 103: 1747-1753.
84. 84. ENDERS, G. et al. 1995. Expression of adhesion molecules on human granulocytes after stimulation with Helicobacter pylori membrane proteins: comparison with membrane proteins of other bacteria. Infect. Immun. 63: 2473-2477.
85. 85. RAUTELIN, H. et al. 1993. Incidence of Helicobacter pylori strains activating neutrophils in patients with peptic ulcer disease. Gut 34: 599-603.
86. 86. EVANS, D. J. et al. 1995. Characterisation of a Helicobacter pylori neutrophil-activating protein. Infect. Immun. 63: 2213-2220.
87. 87. TAKEMURA, T. et al. 1996. Extract of Helicobacter pylori induces neutrophils to injure endothelial cells and contains antielastase activity. Gastroenterology 110: 21-29.
88. 88. MCGOWAN, C. C. et al. 1997. Acid-induced expression of oxidative stress protein homologs in H. pylori. Gut 41(Suppl. 1):A18.
89. 89. CRABTREE, J. E. et al. 1995. Expression of cagA gene and nonopsonic neutrophil activation by Helicobacter pylori. Gut 37(Suppl. 1): A3.
90. 90. DAVIES, G. R. et al. 1995. Reactive oxygen metabolite production by gastric antral mucosa infected with Helicobacter pylori: relationship to CagA seropositivity. Gut 37(Suppl. 1): A30.
91. 91. BAGGIOLINI, M., B. DEWALD & B. MOSER. 1994. Interleukin-8 and related chemotactic cytokines - C-X-C and C-C chemokines. Adv. Immunol. 55: 97-179.
92. 92. SCHALL, T. J. & K. B. BACON. 1994. Chemokines, leukocyte trafficking, and inflammation. Curr. Opin. Immunol. 6: 865-873.
93. 93. SHIMOYAMA, T. et al. 1998. Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J. Clin. Pathol. In press.
94. 94. CRABTREE, J. E. et al. 1994. Interleukin-8 expression in Helicobacter pylori, normal and neoplastic gastroduodenal mucosa. J. Clin. Pathol. 47: 61-66.
95. 95. CRABTREE, J. E. et al. 1994. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cells. J. Clin. Pathol. 47: 945-950.
96. 96. CRABTREE. J. E. et al. 1995. Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J. Clin. Pathol. 48: 41-45.
97. 97. SHARMA, S. A. et al. 1995. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect. Immun. 63: 1681-1687.
98. 98. CRABTREE, J. E. et al. 1997. Helicobacter pylori induction of IL-8 synthesis in gastric epithelial cells depends on genes throughout the cag pathogenicity island. Gut 40(Suppl. 1): A69.
99. 99. AIHARA, M. et al. 1997. Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN 45. Infect. Immun. 65: 3218-3224.
100. 100. SEGAL, E. D. et al. 1997. Induction of host signal transduction pathways by Helicobacter pylori. Proc. Natl. Acad. Sci. USA 94: 7595-7599.
101. 101. MCCOLL, K. E. L. et al. 1998. Helicobacter pylori-induced disturbances of gastric physiology are related to bacterial CagA status. Submitted.
102. 102. D'ELIOS, M. M. et al. 1997. Different cytokine profiles and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer disease. Eur. J. Immunol. 27: 1751-1755.
103. 103. MOHAMMADI, M. et al. 1996. Helicobacter-specific cell mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J. Immunol. 156: 4729-4738.
104. 104. MOHAMMADI, M. et al. 1996. Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains. Infect. Immun. 64: 238-245.
105. 105. HARRIS, A. W. et al. 1997. Recurrence of duodenal ulcer after Helicobacter pylori eradication is realted to high acid output. Aliment. Pharmacol. Ther. 11: 331-334.